Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules

Breast cancer cells exploit the up-regulation or down-regulation of immune checkpoint proteins to evade anti-tumor immune responses. To explore the possible involvement of this mechanism in promoting systemic immunosuppression, the pre-treatment levels of soluble co-inhibitory and co-stimulatory imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Rapoport, Bernardo L., Steel, Helen C., Hlatshwayo, Nomsa, Theron, Annette J., Meyer, Pieter W. A., Nayler, Simon, Benn, Carol-Ann, Smit, Teresa, Kwofie, Luyanda L. I., Heyman, Liezl, Anderson, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168983/
https://www.ncbi.nlm.nih.gov/pubmed/35677046
http://dx.doi.org/10.3389/fimmu.2022.823842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168983/
https://www.ncbi.nlm.nih.gov/pubmed/35677046
http://dx.doi.org/10.3389/fimmu.2022.823842

Ejemplares similares